Skip to content

Evaluation of the efficacy of sacral ere ctor spinae plane block on postoperative pain after total hip arthroplasty: A prospective randomized controlled study

Evaluation of the efficacy of sacral ere ctor spinae plane block on postoperative pain after total hip arthroplasty: A prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105472
Enrollment
Unknown
Registered
2025-07-03
Start date
2025-07-07
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic postsurgical pain

Interventions

Experimental group :Sacral erector spinae block was performed under ultrasound guidance at the level of the second posterior sacral foramen, and 20ml of 0.25% ropivacaine was injected.
control group:No nerve block was given after general anesthesia in the same way.

Sponsors

920th Hospital of the Joint Logistics Support Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1.Total hip arthroplasty with unilateral primary posterolateral approach incision under general anesthesia; 2.Age 18-79 years old; 3.ASAI—? class.

Exclusion criteria

Exclusion criteria: 1. Morbid obesity (BMI>35 kg/m²); 2. Emergency hip replacement; 3. Local anesthetic allergy; 4. Severe coagulopathy (PLT=13%); 7. Have a history of taking analgesic drugs (such as aspirin, celecoxib, ibuprofen, morphine, etc.) for more than 3 months; 8. Those who are unable to use PCA correctly or fail to understand the use of PCA (self-pressing the medication button according to the degree of pain and increasing the dose of painkiller medication pumped); 9. Refusal to participate in this experiment; 10. Severe impaired liver function (alanine aminotransferase (ALAT) or aspartate aminotransferase (ASAT) >100 IU/L or known cirrhosis or liver transplantation); 11. Severe renal impairment (glomerular filtration <30mL/min) or previous kidney transplantation or renal dialysis.

Design outcomes

Primary

MeasureTime frame
NRS scores at 12 h, 24 h, and 48 h after extubation at rest and passive motion of the hip joint on the surgical side were evaluated.;

Secondary

MeasureTime frame
Remifentanil consumption during operation;PCA pressing times of analgesia pump and sufentanil consumption of analgesia pump within 48 hours after operation;Additional Analgesic Drugs in Recovery Room;At 48 h after operation, 15 quality of recovery scales ( QoR-15T ) were evaluated.;Proportion of patients requiring remedial medication after surgery;Postoperative 24 h, 48 h lower limb motor block and block range ( modified Bromage score ); Length of hospital stay;First standing time and time to get out of bed;

Countries

China

Contacts

Public ContactLi Zhigui

People's Liberation Army Joint Logistic Support Force 920th Hospital

LIZG243509@126.com+86 131 5075 4832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026